2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole

C59H39N7 — CID 165151396

IUPAC2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole
SMILESCn1c(-c2ccc(-c3cc(-c4ccc5c(c4)C4c6ccccc6C5c5cc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)ccc54)nc(-c4ccccc4)n3)cc2)nc2ccccc21
InChIInChI=1S/C59H39N7/c1-66-52-24-14-13-23-49(52)62-59(66)40-27-25-36(26-28-40)50-35-51(61-55(60-50)37-15-5-2-6-16-37)41-29-31-45-47(33-41)53-43-21-11-12-22-44(43)54(45)48-34-42(30-32-46(48)53)58-64-56(38-17-7-3-8-18-38)63-57(65-58)39-19-9-4-10-20-39/h2-35,53-54H,1H3
InChIKeyOBVAQLDIVXWFMD-UHFFFAOYSA-N
MW846.01 g/mol
LogP13.20
Rot. Bonds7

About 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole

2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole (PubChem CID 165151396) has the molecular formula C59H39N7 and a molecular weight of 846.01 g/mol. Its IUPAC name is 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole.

Molecular Properties

Compound Name2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole
PubChem CID165151396
Molecular FormulaC59H39N7
Molecular Weight846.01 g/mol
Exact Mass845.33
IUPAC Name2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole
SMILESCn1c(-c2ccc(-c3cc(-c4ccc5c(c4)C4c6ccccc6C5c5cc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)ccc54)nc(-c4ccccc4)n3)cc2)nc2ccccc21
InChIInChI=1S/C59H39N7/c1-66-52-24-14-13-23-49(52)62-59(66)40-27-25-36(26-28-40)50-35-51(61-55(60-50)37-15-5-2-6-16-37)41-29-31-45-47(33-41)53-43-21-11-12-22-44(43)54(45)48-34-42(30-32-46(48)53)58-64-56(38-17-7-3-8-18-38)63-57(65-58)39-19-9-4-10-20-39/h2-35,53-54H,1H3
InChIKeyOBVAQLDIVXWFMD-UHFFFAOYSA-N
XLogP13.20
TPSA82.27 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms66
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500846.01
LogP ≤ 513.20
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole?
The IUPAC name of 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole (CID 165151396) is 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole.
What is the SMILES notation for 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole?
The canonical SMILES for 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole is Cn1c(-c2ccc(-c3cc(-c4ccc5c(c4)C4c6ccccc6C5c5cc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)ccc54)nc(-c4ccccc4)n3)cc2)nc2ccccc21.
What is the InChIKey of 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole?
The InChIKey is OBVAQLDIVXWFMD-UHFFFAOYSA-N. The full InChI is InChI=1S/C59H39N7/c1-66-52-24-14-13-23-49(52)62-59(66)40-27-25-36(26-28-40)50-35-51(61-55(60-50)37-15-5-2-6-16-37)41-29-31-45-47(33-41)53-43-21-11-12-22-44(43)54(45)48-34-42(30-32-46(48)53)58-64-56(38-17-7-3-8-18-38)63-57(65-58)39-19-9-4-10-20-39/h2-35,53-54H,1H3.
What are the key properties of 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole?
2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole has a molecular weight of 846.01 g/mol, XLogP of 13.20, 7 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[6-[11-(4,6-diphenyl-1,3,5-triazin-2-yl)-4-pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2(7),3,5,9(14),10,12,15,17,19-nonaenyl]-2-phenylpyrimidin-4-yl]phenyl]-1-methylbenzimidazole is sourced from PubChem (CID 165151396), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).